Referral vs. Listing for Liver Transplantation
Summary of Lecture by Prof. Sanjaya Satapathy
1. Main Clinical Topic(s) Discussed
This lecture addresses the critical distinction between referral to a transplant center and listing on the transplant waiting list for liver transplantation — a concept frequently tested on ABIM/ABIM Transplant Hepatology Board examinations.
2. Key Learning Points, Guidelines, and Recommendations
Core Principle:
- Referral and listing are not synonymous — referral should occur earlier and does not automatically lead to listing
- ABIM frequently tests scenarios where referral is appropriate even when listing is not yet indicated
Definitions:
- Referral: Sending a patient to a transplant center for evaluation
- Listing: Formally placing a patient on the transplant waiting list
Indications for Early Referral:
- First episode of hepatic decompensation (e.g., ascites, variceal bleeding)
- MELD score ≥ 15
- Recurrent complications of cirrhosis
- Hepatocellular carcinoma (HCC) or other transplant-eligible malignancies (e.g., cholangiocarcinoma, colorectal liver metastases with well-treated primary)
- MELD underestimation scenarios, including:
- Primary sclerosing cholangitis (PSC)
- Hepatopulmonary syndrome
- Portopulmonary hypertension
- Recurrent hospitalizations or progressive liver disease despite low MELD score
Criteria Required Before Listing:
- Clear survival benefit from transplantation
- No absolute contraindications present
- Psychosocial evaluation completed
- Medical optimization achieved
- Patient must be ready medically, surgically, and psychosocially
Dynamic Nature of Listing:
- Listing status is not permanent or automatic
- Patients may be: deferred, made temporarily inactive, or removed from the list
- Contraindications delay listing but should not delay referral
3. Specific Clinical Data, Statistics, or Study Results Cited
- No formal study data or statistics were cited in this lecture
- Clinical thresholds referenced:
- MELD ≥ 15: Threshold cited as a referral trigger
- MELD = 12: Illustrated in a board scenario — referral appropriate despite listing not yet indicated
- MELD = 22 with active bacteremia/vasopressors: High MELD does not override active contraindications to listing
- MELD = 25 with 90% coronary artery stenosis (e.g., LAD): Cardiac disease must be addressed before listing decisions are finalized
4. Practical Takeaways for Clinicians
- Refer early, list when appropriate: Do not wait for critical illness before initiating transplant evaluation — this risks missing the transplant window
- High MELD ≠ automatic listing: Active infections, hemodynamic instability, or significant untreated comorbidities (e.g., severe CAD) are contraindications that must be resolved first
- MELD underestimates severity in certain conditions (PSC, hepatopulmonary syndrome, portopulmonary hypertension) — these patients warrant early referral regardless of absolute MELD score
- First decompensation is a referral trigger, even if the patient appears clinically manageable
- Contraindications delay listing, not referral — patients should be seen by a transplant hepatologist to actively work toward resolving barriers
- Clinicians should consistently ask: *"Is this a referral question or a listing question?"* — the answer changes management
*This lecture is part of the ABIM Transplant Hepatology Board Review Course. The next lecture will address absolute and relative contraindications to liver transplantation.*